|
NARS expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.081900E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.093230E-01 |
| Normal-vs-Stage2 |
4.547200E-01 |
| Normal-vs-Stage3 |
2.443100E-03 |
| Normal-vs-Stage4 |
2.114100E-02 |
| Stage1-vs-Stage2 |
3.178200E-02 |
| Stage1-vs-Stage3 |
3.497700E-02 |
| Stage1-vs-Stage4 |
2.398000E-01 |
| Stage2-vs-Stage3 |
3.138500E-03 |
| Stage2-vs-Stage4 |
1.417760E-02 |
| Stage3-vs-Stage4 |
6.850400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.407780E-02 |
| Normal-vs-AfricanAmerican |
4.568800E-01 |
| Normal-vs-Asian |
1.534980E-01 |
| Caucasian-vs-AfricanAmerican |
3.641800E-01 |
| Caucasian-vs-Asian |
5.326000E-01 |
| AfricanAmerican-vs-Asian |
7.112400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.281800E-02 |
| Normal-vs-Female |
8.093600E-02 |
| Male-vs-Female |
5.026000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.445900E-02 |
| Normal-vs-Age(41-60Yrs) |
2.876500E-02 |
| Normal-vs-Age(61-80Yrs) |
2.340000E-01 |
| Normal-vs-Age(81-100Yrs) |
4.098300E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.606000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.033200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.932800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.670400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.871400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.918580E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.136600E-01 |
| Classical-VS-Follicular |
2.417400E-03 |
| Classical-VS-Other |
7.044600E-01 |
| Classical-VS-Normal |
4.664200E-02 |
| Tall-VS-Follicular |
2.921800E-03 |
| Tall-VS-Other |
9.633600E-01 |
| Tall-VS-Normal |
2.409900E-02 |
| Follicular-VS-Other |
4.334000E-02 |
| Follicular-VS-Normal |
3.465800E-01 |
| Other-VS-Normal |
1.928780E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.555850E-01 |
| Normal-vs-N1 |
6.899700E-03 |
| N0-vs-N1 |
9.502400E-02 |
|
|
